Health Catalyst Inc (NASDAQ:HCAT) price on Thursday, February 27, fall -11.13% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $4.39.
A look at the stock’s price movement, the close in the last trading session was $4.94. Turning to its 52-week performance, $9.24 and $4.76 were the 52-week high and 52-week low respectively. Overall, HCAT moved -24.31% over the past month.
Health Catalyst Inc’s market cap currently stands at around $267.12 million, with investors looking forward to this quarter’s earnings report slated for in March.
Analysts have a consensus estimate of 79.25M for the company’s revenue for the quarter, with a low and high estimate of 78.68M and 80.4M respectively. The average forecast suggests up to a 6.05% growth in sales growth compared to quarterly growth in the same period last fiscal year. Wall Street analysts have also projected the company’s year-on-year revenue to grow to 334.59M, representing a 9.13% jump on that reported in the last financial year.
Turning to the stock’s technical picture we see that short term indicators suggest on average that HCAT is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
11 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 3 analyst(s) rate the stock as a Hold, 8 recommend HCAT as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
HCAT’s current price about -18.58% and -28.56% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 24.84, while 7-day volatility ratio is 10.84% and 6.16% in the 30-day chart. Further, Health Catalyst Inc (HCAT) has a beta value of 1.40, and an average true range (ATR) of 0.36. Analysts have given the company’s stock an average 52-week price target of $9, forecast between a low of $7 and high of $11. Looking at the price targets, the low is -59.45% off current price level while to achieve the yearly target high, price needs to move -150.57%. Nonetheless, investors will most likely welcome a -105.01% jump to $9 which is the analysts’ median price.
If we refocus on Health Catalyst Inc (NASDAQ:HCAT), historical trading data shows that trading volumes averaged 697.45K over the past 3 months. The company’s latest data on shares outstanding shows there are 64.04 million shares.
The 5.54% of Health Catalyst Inc’s shares are in the hands of company insiders while institutional holders own 89.23% of the company’s shares. Current price change has pushed the stock -37.91% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the HCAT stock continues to rise going into the next quarter.
